Dave Rabin, a neuroscientist and psychiatrist renowned for his work on the Apollo Neuro device, joins to explore the intersection of vibrations and mental health. They discuss how vibrations can replicate the benefits of MDMA therapy in enhancing neuroplasticity and emotional healing without drugs. Rabin elaborates on the Apollo device's ability to regulate stress, improve focus, and aid recovery by harnessing the body's natural responses to sound. The conversation also delves into innovative approaches for treating ADHD and the importance of emotional connections in well-being.

In this conversation with Dave Rabin, a neuroscientist and co-founder of Apollo Neuroscience, listeners dive into the transformative power of the Apollo Neuro wearable device. Dave explains how it can enhance focus, improve sleep, and boost mood without any drugs. He discusses the fascinating science behind haptic feedback and its connection to emotional and physical wellness. Topics also include the emerging field of MDMA therapy and how technology can promote emotional connections, making daily interactions more meaningful.

Dr. Dave Rabin, a psychedelic healthcare expert, discusses the potential of psychedelic-assisted therapy for mental illnesses. Topics covered include the misconceptions surrounding serotonin and its relationship to depression, the benefits of ketamine in increasing neurogenesis and neuroplasticity, and different administration methods for ketamine. The podcast also explores the impact of chronic stress on gene expression and the need for a shift in the perception and treatment of mental illness.

Dr. Dave Rabin, a psychiatrist, neuroscientist, and founder of Apollo Neuro, discusses strategies for reducing chronic stress, improving sleep quality, and enhancing focus and energy levels. He shares his research on non-invasive therapies for PTSD, anxiety disorders, and addictions. Vibration therapy through Apollo Neuro is highlighted as a powerful tool for reducing stress and calming the nervous system. The discussion also addresses the mental health epidemic, the impact of touch deprivation, and the role of breathing rhythm in our well-being.

Dr. Dave Rabin, a leading medical professional, joins retired army sergeant Jon Lubecky, who participated in MAPS MDMA therapy trials, to discuss the FDA's recent rejection of MDMA-assisted therapy. They delve into the implications of this decision and its impact on veterans seeking help. Unethical behavior from organizations like Symposia, including falsifying information, raises serious ethical concerns. The conversation emphasizes the urgent need for continued advocacy, transparency, and hope for future access to these transformative treatments.